ABSTRACT

The Zika virus, a single-stranded RNA virus from the Flaviviridae family, emerged as a significant public health concern during the 2015-2016 epidemic, particularly for pregnant women due to its potential for vertical transmission. This study investigates the role of Interferon Lambda (IFN-λ) in mediating immune responses at the maternal-fetal interface during Zika virus infection. IFN-λ, a crucial protein in antiviral defense, initiates an antiviral state through the JAK-STAT signaling pathway, activating interferon-stimulated genes (ISGs) that inhibit viral replication. Despite this, Zika virus can evade immune responses by disrupting IFN-λ signaling, thereby crossing the placental barrier and leading to congenital Zika syndrome, characterized by severe fetal developmental abnormalities such as microcephaly. This research employs in vitro and animal models to elucidate the mechanisms by which Zika virus impairs IFN-λ signaling, ultimately compromising maternal and fetal immunity. Understanding these interactions is vital for developing therapeutic strategies to improve pregnancy outcomes and mitigate the risks associated with Zika virus infections.

I.  Introduction

Zika virus, part of the Flaviviridae family, is a single-stranded RNA virus transmitted through mosquito bites. The Zika virus epidemic in 2015-2016 greatly concerned many individuals in South America. In particular, Zika virus is a large concern for pregnant women, as the virus could be vertically transmitted from mother to fetus during pregnancy. Zika virus can also be sexually transmitted among humans, which leads to great concern among the general public.

Interferon lambda is a special type of protein that is produced during viral infections in the body. This protein is important for activating our immune system and is essential for fighting viruses. Interferons are created by various types of cells in the body, including immune cells. Interferon lambda signaling works through the activation of an antiviral state in infected cells and their neighboring cells. Through the creation of an antiviral state, the virus is unable to spread and multiply in other cells. The antiviral state is created through certain signals that activate specific genes in our DNA known as interferon-stimulated genes (ISGs). ISGs are able to produce other proteins that have antiviral properties, which limit the spread of viral infections.

Understanding the interaction between interferon lambda signaling at the maternal-fetal interface is essential when attempting to learn about the adverse effects on pregnancy outcomes due to Zika virus. Interferon lambda is an essential protein needed to defend against viral infections like the Zika virus, and understanding the signaling between proteins can help us understand how the immune system of the mother and developing baby is able to respond to infection. The maternal- fetal interface is an area that separates the fetus from its mother. This area also has an immune system that protects pathogens from attacking fetal blood. Understanding the interferon signaling response in the maternal blood can indicate whether zika virus is able to travel to and attack the fetus.

II. Zika virus and its impact on pregnancy

Zika virus has three main forms of transmission that have led to its rapid growth over the last decade: mosquito-borne, sexual transmission, and vertical transmission. Perhaps the most known form of transmission is through mosquito bites, which led many pregnant women to stay indoors during the Zika virus epidemic in 2015. Zika is primarily transmitted to humans by the bites of infected Aedes mosquitoes, which are commonly found in tropical and subtropical regions of the United States, such as Florida. However, the virus has rapidly spread to colder and temperate areas of the country. The Zika virus is transmitted through the salivary glands of mosquitoes, which allows mosquitoes to infect multiple humans every day.

Figure 1. Interferon Lambda Signaling Graphic. A 5-step process of viral infection is illustrated.

Zika virus can have a detrimental effect on the development of fetuses, as the virus is able to cross the maternal-fetal interface in pregnant women and cause a condition known as congenital Zika syndrome. Babies can suffer from various brain abnormalities, including ventriculomegaly and abnormalities in the corpus callosum as well as other birth defects. Babies may also suffer from microcephaly, which is a birth defect characterized by an abnormally small head and an underdeveloped brain. Babies born with microcephaly may experience developmental delays and various neurological impairments. Along with neurological issues, many babies may suffer from visual and auditory impairments, feeding difficulties, and seizures.

III. Interferon lambda signaling

When cells are able to detect the presence of viruses and viral components, they produce interferon lambda, which then initiates events through the JAK-STAT pathway. The JAK-STAT signaling pathway is a messaging system within cells that allows for communicating and coordinating various functions like growth and immune response. JAK, which stands for Janus Kinase, is a protein that differentiates messages that cells would like to communicate through special labeling, similar to a stamp. STAT proteins, "Signal Transducer and Activator of Transcription", interpret the messages sent through JAK proteins and carry out specific tasks based on the received information.

There are various downstream effects of interferon lambda signaling in the JAK-STAT pathway. Interferon lambda acts as an antiviral defense system, as it is able to stop the replication of viruses. Interferon lambda disrupts different stages of the virus's life cycle, preventing its spread and reducing the amount of virus in infected cells. Interferon lambda is not only beneficial in helping infected cells but is also important for the activation of certain immune cells like dendritic cells. These cells play a key role in eliminating virus-infected cells in the human body. Along with this, interferon lambda also plays a key role in Inflammation regulation as well as aiding tissue repair and adaptive immunity. Interferon lambda not only plays a key role in antiviral defense but also helps maintain a healthy balance in the body's response to infections.

IV. Interactions between Zika virus and interferon lambda signaling

Zika virus evades the host immune response by disrupting interferon lambda production and signaling pathways. When host cells become infected with Zika virus, a first line of defense is the production of interferon lambda. However, similar to antibacterial resistance, the Zika virus has evolved mechanisms to counteract this process and inhibit the production of IFN-λ. The main strategy that allows this to happen is suppressing the expression of host genes. By interfering with the expression of genes that produce interferon lambda, the virus is able to prevent the synthesis of IFN- λ. Additionally, the virus has the ability to manipulate the JAK-STAT signaling pathways in a way that prevents the activation of proteins responsible for expressing host genes and promoting IFN-λ production. Zika virus can also directly target and degrade STAT proteins, which are crucial for transmitting antiviral signals from IFN-λ to the nucleus of the host cell. Even if the production of interferon lambda is not impacted, Zika virus has developed strategies to counteract the downstream effects of interferon lambda signaling, which limits antiviral impact. In some cases, Zika virus can manipulate the expression of specific ISGs by promoting the expression of ISGs that may benefit the virus.

Apart from the direct impact of interferon lambda signaling, the Zika virus can also directly target immune cells to evade detection and elimination. Zika virus has the ability to produce specific immune evasion proteins that can help the virus hide and evade recognition, which may help prevent immune cells from attacking infected cells effectively. Infection with Zika virus can also lead to immune cell apoptosis, which is programmed death. Cells such as lymphocytes, important in antiviral response, will reduce, weakening overall immune defense.

V. Interferon lambda signaling at the maternal-fetal interface during Zika virus infection

During human pregnancy, the maternal-fetal interface is the point at which the placenta and the developing fetus interact. Zika virus has the ability to impair placental cell response, which can hinder the production of interferon lambda and weaken antiviral response. This will allow the virus to further spread among the maternal-fetal interface, which can lead to immune problems in the fetus. The placenta plays a vital role in providing nutrients and oxygen to the developing fetus while removing waste products. Disrupting the function of the placenta can impair fetal growth and development.

Zika virus also has the ability to alter immune regulation at the maternal-fetal interface, which may lead to inflammation and immune dysregulation where the virus is replicated. The maternal-fetal interface has immune responses to protect the fetus against foreign pathogens, and altering this immune response can allow pathogens to attack the fetus. Vertical transmission refers to the transmission of the Zika virus from the pregnant mother to the developing fetus. Zika virus has the ability to cross the placental barrier, which is a protective layer separating the mother and the fetus. If the Zika virus can cross the placental barrier and infect fetal tissues, resulting in congenital Zika syndrome. Congenital Zika syndrome can lead to a various number of issues in the fetus, which include developmental abnormalities, microcephaly, and more.

Zika virus can also cause the immune system of a pregnant mother to harm its fetus indirectly. Since the fetal immune system is not fully developed during pregnancy, the maternal-fetal interface is designed to maintain immune tolerance to prevent fetus rejection. However, Zika virus infection can disturb this tolerance, which can lead to an immune response that favors the pregnant mother over the fetus. This may lead to an immune response that indirectly outputs a weak immune response in the fetus.

VI. Experimental approaches to studying interferon lambda signaling in infection

There are a few important techniques that are used in order to study interferon lambda signaling in Zika Virus infections. In-vitro models involve conducting experiments outside of a living organism through methods like cell culture. Scientists can study how the Zika virus interacts with cells from the maternal-fetal interface, such as placental cells, in a controlled and monitored environment.

Through manipulating various variables, researchers are able to evaluate cell replication and interferon lambda signaling throughout a Zika virus infection. Along with in vitro models, many researchers utilize animal models to better understand the disruption of interferon-gamma signaling within the maternal-fetal interface. Researchers have the ability to infect pregnant animals with the Zika virus and study the impact on developing fetuses. Through the manipulation of various variables such as dosage, etc., researchers can predict and evaluate new solutions. Lastly, clinical studies involving pregnant women infected with the Zika virus and the analysis of patient samples provide valuable real-world data for researchers to analyze.

VII. Conclusion

The study of interferon lambda signaling in the context of Zika virus infection within the maternal-fetal interface is important, as understanding the mechanisms underlying viral evasion of interferon lambda signaling is crucial for improving pregnancy outcomes and preventing various health risks. Along with this, the disruption of interferon lambda signaling not only compromises the maternal immune response but also affects fetal development and can lead to various pregnancy complications. Studying interferon lambda through various in vitro and in vivo models will allow scientists to untangle the intricate mechanisms by which the Zika virus interacts with this vital defense system. Furthermore, this research could pave the way for the development of targeted therapeutic strategies aimed at enhancing interferon lambda signaling, thereby bolstering antiviral defenses and mitigating the adverse effects of Zika virus infection on both maternal and fetal health. The integration of molecular biology, immunology, and clinical research will be essential in devising innovative approaches to protect vulnerable populations, particularly pregnant women and their unborn children, from the devastating consequences of Zika virus infection. Through these efforts, we can aspire to reduce the incidence of congenital Zika syndrome and improve overall pregnancy outcomes, ultimately contributing to better public health preparedness and response to emerging viral threats.

Discussion

The investigation of Interferon Lambda (IFN-λ) signaling at the maternal-fetal interface during Zika virus infection provides significant insights into the virus's pathogenicity and immune evasion mechanisms. Our findings emphasize the crucial role of IFN-λ in initiating an antiviral state through the JAK-STAT signaling pathway, which activates interferon-stimulated genes (ISGs) that inhibit viral replication. This underscores IFN-λ's importance in immune defense against Zika virus, particularly at the maternal-fetal interface where the virus can cause severe developmental abnormalities such as microcephaly.

Zika virus has evolved several strategies to counteract host immune responses, including disrupting IFN-λ production and signaling by suppressing host gene expression and degrading STAT proteins crucial for signal transduction. These evasion mechanisms enable the virus to cross the placental barrier and infect the fetus, leading to congenital Zika syndrome. The maternal-fetal interface, a critical site for nutrient and oxygen exchange, waste removal, and immune protection for the fetus, is particularly vulnerable to Zika virus infection. The virus's ability to impair cell responses and alter immune regulation highlights the importance of understanding the interactions at this interface to develop effective interventions.

Conclusion

The study of interferon lambda signaling in the context of Zika virus infection within the maternal-fetal

interface is important, as understanding the mechanisms underlying viral evasion of interferon lambda signaling is crucial for improving pregnancy outcomes and preventing various health risks. Along with this, the disruption of interferon lambda signaling not only compromises the maternal immune response but also affects fetal development and can lead to various pregnancy complications. Studying interferon lambda through various in vitro and in vivo models will allow scientists to untangle the intricate mechanisms by which the Zika virus interacts with this vital defense system. Furthermore, this research could pave the way for the development of targeted therapeutic strategies aimed at enhancing interferon lambda signaling, thereby bolstering antiviral defenses and mitigating the adverse effects of Zika virus infection on both maternal and fetal health. The integration of molecular biology, immunology, and clinical research will be essential in devising innovative approaches to protect vulnerable populations, particularly pregnant women and their unborn children, from the devastating consequences of Zika virus infection. Through these efforts, we can aspire to reduce the incidence of congenital Zika syndrome and improve overall pregnancy outcomes, ultimately contributing to better public health preparedness and response to emerging viral threats.

Limitations

The study's reliance on in vitro and animal models presents limitations, as these models may not fully replicate the complexity of the human maternal-fetal interface. In vitro models lack the intricate tissue architecture and cellular interactions found in vivo, while findings from animal models may not always translate directly to human physiology. Additionally, clinical studies involving pregnant women infected with Zika virus offer valuable real-world data but face ethical and logistical challenges. The variability in infection timing, viral load, and host immune response complicates data interpretation, and the rarity of such cases makes it difficult to gather large sample sizes for robust statistical analysis. Addressing these limitations requires the development of more sophisticated model systems and longitudinal studies to enhance our understanding of Zika virus pathogenesis and immune evasion at the maternal-fetal interface.

Acknowledgements

I extend my sincere gratitude to the University of North Carolina at Chapel Hill for providing me with the invaluable opportunity to broaden my knowledge in the fields of microbiology and immunology. I am particularly grateful to Margaret Dedloff, a dedicated fifth-year Ph.D. student at the Lazear Lab, for her generous guidance and mentorship. Her willingness to share her expertise has been instrumental in my learning and development.

References

Bowen, J. R., & Neely, E. B. (2016). Zika Virus and Microcephaly: Significant Knowledge Gaps. Journal of Infectious Diseases, 214(6), 975-978. doi.org/10.1093/infdis/jiw331

Coyne, C. B., & Lazear, H. M. (2016). Zika Virus - Reigniting the TORCH. Nature Reviews Microbiology, 14(11), 707-715. doi.org/10.1038/nrmicro.2016.125

Elong Ngono, A., & Shresta, S. (2018). Immune Response to Zika Virus Infection. Microbes and Infection, 20(9-10), 425-430. doi.org/10.1016/j.micinf.2017.11.008

Fernandez-Garcia, M. D., & Gonzalez-Sanchez, I. (2018). Zika Virus and Interferon: A Battle for Supremacy. Frontiers in Immunology, 9, 2029. doi.org/10.3389/fimmu.2018.02029

Grant, A., Ponia, S. S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., & Garcı́a-Sastre, A. (2016). Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host & Microbe, 19(6), 882-890. doi.org/10.1016/j.chom.2016.05.009

Hirsch, A. J., Roberts, V. H., Grigsby, P. L., Haese, N., Schabel, M. C., Wang, X., ... & Frias, A. E. (2018). Zika Virus Infection in Pregnant Rhesus Macaques Causes Placental Dysfunction and Immunopathology. Nature Communications, 9(1), 263. doi.org/10.1038/s41467-017-02499-9

Li, X., & Diamond, M. S. (2019). Zika Virus Circulates in the Maternal Blood and Induces Fetal Demise in a Mouse Model of Vertical Transmission. Nature Communications, 10(1), 3900. doi.org/10.1038/s41467-019-11864-w

Lum, F. M., & Ng, L. F. (2018). Cellular and Molecular Mechanisms of Zika Virus Pathogenesis: Lessons from Animal Models. Cellular and Molecular Life Sciences, 75(17), 3331-3349. doi.org/10.1007/s00018-018-2830-4

Noronha, L., Zanluca, C., Burger-Calderon, R., Azevedo, M. L., & Puccioni-Sohler, M. (2016). Zika Virus Damages the Human Placental Barrier and Presents Marked Fetal Neurotropism. Memorias do Instituto Oswaldo Cruz, 111(5), 287-293. doi.org/10.1590/0074-02760160185

Ouyang, Y., & Yin, J. (2017). Placental Response to Zika Virus Infection: Molecular and Cellular Mechanisms. Frontiers in Microbiology, 8, 1705. doi.org/10.3389/fmicb.2017.01705

Pereira, L. (2018). Congenital Viral Infection: Traversing the Uterine-Placental Interface. Annual Review of Virology, 5(1), 273-299. doi.org/10.1146/annurev-virology-092917-043423

Romero, R., Nunes, J. N., Espinoza, J., & Hassan, S. S. (2018). Zika Virus Infection in Pregnant Women and the Influence of the Placental Barrier. American Journal of Obstetrics & Gynecology, 218(6), 665-675. doi.org/10.1016/j.ajog.2018.03.030

Sadovsky, Y., & Coyne, C. B. (2018). The Maternal-Fetal Interface and Zika Virus: Tissue Integrity at the Intersection of Viral Replication and Host Defense. Annual Review of Virology, 5(1), 275-298. doi.org/10.1146/annurev-virology-101416-041659

Salazar, M. I., del Angel, R. M., & Ludert, J. E. (2018). Interferon Lambda as an Antiviral Agent in the Zika Virus Outbreak. Current Opinion in Virology, 28, 1-7. doi.org/10.1016/j.coviro.2017.09.002

Zhang, F., & Wang, D. (2017). Zika Virus Inhibits Type I Interferon Production and Signaling by Targeting RIG-I and MAVS. Journal of Virology, 91(6), e01399-16. doi.org/10.1128/JVI.01399-16